1.Khalil Ibrahim A. Trends of adult primary malignant renal tumors over 6 years[J]. Pak J Med Sci, 2013, 29(6): 1385-1388.
2.National Cancer Institute. Cancer of the kidney and renal pelvis seer stat fact sheets. 2016, Available online:https://seer.cancer.gov/statfacts/html/kidrp.html
3. Jia Y, Zuo D, Li Z, et al. Astragaloside IV inhibits doxorubicin-induced cardiomyocyte apoptosis mediated by mitochondrial apoptptic pathway via activating the PI3K/Akt pathway [J]. Chem Pharm Bull(Tokyo),2014,62(1):45-53.
4.Bodnar L, Stec R, Cierniak S, et al. Clinical usefulness of PI3K/Akt/mTOR genotyping in companion with other clinical variables in metastatic renal cell carcinoma patients treated with everolimus in the second and subsequent lines [J]. Ann Oncol,2015,26(7):1385-1389.
5.Jain R, Sharma A, Gupta S, et al. Solanum nigrum: current perspectives on therapeutic properties [J]. Altern Med Rev, 2011, 16(1):78-85.
6.Al Sinani SS, Eltayeb EA, Coomber BL, et al. Solamargine triggers cellular necrosis selectively in different types of human melanoma cancer cells through extrinsic lysosomal mitochondrial death pathway[J]. Cancer Cell Int,2016,16: 11.
7.Pan B, Zhong W, Deng Z, et al. Inhibition of prostate cancer growth by solanine requires the suppression of cell cycle proteins and the activation of ROS /P38 signaling pathway [J].Cancer Med,2016,5( 11) : 3214-3222.
8.Zhang F,Yang R,Zhang G,et al.Anticancer function of α-solanine in lung adenocarcinoma cells by inducing micro RNA-138 expression[J]. Tumor Biol,2016,37( 5) : 6437-6346.
9 Wen Z,Huang C,Xu Y,et al.α-Solanine inhibits vascular endothelial growth factor expression by down-regulating the ERK1 /2-HIF-1α and STAT3 signaling pathways[J].Eur J Pharmacol,2016,771( 15) : 93-98.
10. Mohsenikia M, Farhangi B, Alizadeh A M, et al.Therapeutic effects of dendrosomal solanine on a metastatic breast tumor [J]. Life Sci, 2016, 148(7):
260-267.
11. Deng J. How to unleash mitochondrial apoptotic blockades to kill cancers? [J]. Acta Pharm Sin B, 2017,7(1): 18-26.
12. Ying Y, Padanilam B J. Regulation of necrotic cell death: p53, PARP1 and cyclophilin D-overlapping pathways of regulated necrosis? [J]. Cell Mol Life Sci, 2016,73(11/12): 2309-2324.
13. Lv C, Kong H, Dong G, et al. Antitumor efficacy of α-solanine against pancreatic cancer in vitro and in vivo[J]. PLoS One, 2014, 9(2): e87868.
14. Mohsenikia M, Alizadeh A M, Khodayari S, et al. The protective and therapeutic effects of alpha-solanine on mice breast cancer [J]. Euro J Pharm, 2013, 718(1/3): 1-9.
15. Mohsenikia M, Farhangi B, Alizadeh A M, et al. Therapeutic effects of dendrosomal solanine on a metastatic breast tumor [J]. Life Sci, 2016,148(7):260-267.
16. Mazzoletti M,Broggini M. PI3K/Akt /m-TOR inhibitors in ovarian cancer[J].Curr Med Chem,2010,17( 36) : 4433.
17. Saini K S,Loi S,de Azambuja E,et al. Targeting the PI3K/AKT /mTOR and Raf /MEK/ERK pathways in the treatment of breast cancer[J]. Cancer Treat Rev,2013,39( 8) : 935.
18.Karar J,Maity A. PI3K/Akt/mTOR pathway in angiogenesis[J].Front Mol Neurosci,2011,4(51):1-7.